Alzheimer?s Disease: A Review - Primary Care Reports - Jul 01, 2005

Target Audience:

This activity is intended for the family practitioner and internist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Authors
Daniel J. Tambunan, MD
Florida Hospital
Orlando, FL

Ariel F Cole, MD
Director
Geriatric Fellowship
Assistant Director
Florida Hospital Family Medicine Residency

Rhonda L. Randall, DO
Evercase-Florida
State Medical Director - Community Programs
Hospice of the Comfoter
Altamonte Springs, FL
Team Physician

Peer Reviewer
Alan Z. Segal, MD
Assistant Professor
Department of Neurology
Weill-Cornell Medical College
New York Presbyterian Hospital

Editor-In-Chief
Gregory R. Wise, MD, FACP
Associate Professor of Medicine
Wright State University
Dayton, Ohio;
Vice President, Medical Affairs
Kettering Medical Center
Kettering, Ohio

Subjects:

  • Alzheimer’s Disease: A Review

Objectives:

  • Summarize the most recent significant primary care medicine-related studies
  • Discuss up-to-date information on all aspects of primary care, including new drugs, techniques, equipment, trials, studies, books, teaching aids, and other information pertinent to primary care
  • Evaluate the credibility of published data and recommendations
  • Describe the pros and cons of new testing procedures

Financial Disclosure:

To reveal any potential bias in this publication, we disclose that Gregory R. Wise, MD, FACP (editor), Ariel F Cole, MD, and Rhonda L. Randall, DO (co-authors), and Alan Z. Segal, MD (peer reviewer) report no consultant, stockholder, speaker's bureau, research, or other financial relationships with companies having ties to this field of study. Daniel J. Tambunan, MD (co-author) reports he is on the speaker's bureaus for Pfizer, Wyeth, Astra-Zeneca and GlaxoSmithKline, and receives research funding from Astra-Zeneca.

Copyright 2005 AHC Media. All rights reserved.